These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 27294383)

  • 1. [Drug-drug interactions in the elderly : Which ones really matter?].
    Bitter K; Schlender JF; Woltersdorf R
    Internist (Berl); 2016 Jul; 57(7):728-34. PubMed ID: 27294383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trial.
    Stingl JC; Kaumanns KL; Claus K; Lehmann ML; Kastenmüller K; Bleckwenn M; Hartmann G; Steffens M; Wirtz D; Leuchs AK; Benda N; Meier F; Schöffski O; Holdenrieder S; Coch C; Weckbecker K
    BMC Fam Pract; 2016 Apr; 17():49. PubMed ID: 27112273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adverse drug reactions in the elderly: What dermatologists should know].
    Kratzsch D; Simon JC; Treudler R
    Hautarzt; 2016 Feb; 67(2):125-31. PubMed ID: 26643292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
    Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
    Trials; 2016 Jan; 17():57. PubMed ID: 26822311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and pilot testing of PHARAO-a decision support system for pharmacological risk assessment in the elderly.
    Böttiger Y; Laine K; Korhonen T; Lähdesmäki J; Shemeikka T; Julander M; Edlert M; Andersson ML
    Eur J Clin Pharmacol; 2018 Mar; 74(3):365-371. PubMed ID: 29198061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dermatosurgery in the elderly].
    Meissner M; Kaufmann R
    Hautarzt; 2016 Feb; 67(2):153-9. PubMed ID: 26743055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of adverse drug reactions in older patients].
    Burkhardt H; Wehling M; Gladisch R
    Z Gerontol Geriatr; 2007 Aug; 40(4):241-54. PubMed ID: 17701115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polypharmacy - Solutions for Enhanced Drug Safety].
    Krause O; Picksak G; Junius-Walker U
    Dtsch Med Wochenschr; 2017 Jul; 142(14):1046-1053. PubMed ID: 28728199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Australian and New Zealand Society for Geriatric Medicine: position statement - frailty in older people.
    Hubbard R; Ng K;
    Australas J Ageing; 2015 Mar; 34(1):68-73. PubMed ID: 25735472
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
    Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
    Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geriatric Polypharmacy: Pharmacist as Key Facilitator in Assessing for Falls Risk: 2019 Update.
    Fritsch MA; Shelton PS
    Clin Geriatr Med; 2019 May; 35(2):185-204. PubMed ID: 30929882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions in special populations - the elderly.
    Davies EA; O'Mahony MS
    Br J Clin Pharmacol; 2015 Oct; 80(4):796-807. PubMed ID: 25619317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. District nurses' use of a decision support and assessment tool to improve the quality and safety of medication use in older adults: a feasibility study.
    Lagerin A; Lundh L; Törnkvist L; Fastbom J
    Prim Health Care Res Dev; 2020 Jun; 21():e15. PubMed ID: 32495732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical decision support systems: great promises for better management of patients' drug therapy.
    Turgeon J; Michaud V
    Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):993-5. PubMed ID: 27021287
    [No Abstract]   [Full Text] [Related]  

  • 15. Geriatric Polypharmacy: Pharmacist as Key Facilitator in Assessing for Falls Risk.
    Fritsch MA; Shelton PS
    Clin Geriatr Med; 2017 May; 33(2):205-223. PubMed ID: 28364992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopharmacological Treatment in Older People: Avoiding Drug Interactions and Polypharmacy.
    Kratz T; Diefenbacher A
    Dtsch Arztebl Int; 2019 Jul; 116(29-30):508-518. PubMed ID: 31452508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypharmacy: the challenge for nurses.
    Kaufman G
    Nurs Stand; 2016 May; 30(39):52-60. PubMed ID: 27224631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug effects in elderly people -- a disparity between clinical examination and adverse effects self-reported by the patient.
    Lampela P; Hartikainen S; Sulkava R; Huupponen R
    Eur J Clin Pharmacol; 2007 May; 63(5):509-15. PubMed ID: 17351768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacotherapy in the elderly: primum non nocere!].
    Scheen AJ
    Rev Med Liege; 2014; 69(5-6):282-6. PubMed ID: 25065233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polypharmacy and drug interactions in elderly patients].
    Yıldırım AB; Kılınç AY
    Turk Kardiyol Dern Ars; 2017 Sep; 45(Suppl 5):17-21. PubMed ID: 28976374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.